Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

10,870 total articles

Humacyte Announces Symvess® is Now Under Contract with the Strategic Acquisition Center (SAC) of the U.S. Department of Veterans Affairs

Humacyte Announces Symvess® is Now Under Contract with the Strategic Acquisition Center (SAC) of the U.S. Department of Veterans Affairs

Humacyte, Inc., a biotech company specializing in bioengineered human tissues, announced that its FDA-approved product Symvess is now under contract with the U.S. Department of Veterans Affairs Strategic Acquisition Center (SAC). This contract streamlines Symvess's accessibility and approval process across 170 VA hospitals, enhancing treatment opti…

Phathom Pharmaceuticals Highlights Breadth of Independent Vonoprazan Research at Digestive Disease Week 2026 Annual Meeting

Phathom Pharmaceuticals Highlights Breadth of Independent Vonoprazan Research at Digestive Disease Week 2026 Annual Meeting

Phathom Pharmaceuticals highlighted the breadth of independent and company-sponsored clinical research on vonoprazan, a novel potassium-competitive acid blocker used for various gastrointestinal (GI) conditions, at Digestive Disease Week (DDW) 2026. The presentation included 31 abstracts, with 28 independent studies and 3 Phathom-sponsored analyses…

Preferred Bank Announces Recovery Settlement

Preferred Bank Announces Recovery Settlement

Preferred Bank announced a settlement agreement to recover $5.7 million over eleven months on a commercial and industrial loan that was charged off in Q2 2024. This recovery strengthens the bank's financial position and positively impacts its asset quality.

AMASS Brands Group Completes Nasdaq Direct Listing; Common Stock to Begin Trading Under the Symbol ‘AMSS’

AMASS Brands Group Completes Nasdaq Direct Listing; Common Stock to Begin Trading Under the Symbol ‘AMSS’

AMASS Brands Group, a multi-category beverage company with brands spanning non-alcoholic, functional wellness, and alcohol 2.0 products, completed its Nasdaq direct listing under ticker AMSS. The company, which has generated over $80 million in revenue and expanded distribution to 40,000 points of sale, aims to capitalize on growing consumer trends…

Absci to Participate in Upcoming Investor Conferences

Absci to Participate in Upcoming Investor Conferences

Absci Corporation announced its participation in the 2026 Jefferies Global Healthcare Conference and the Goldman Sachs 47th Annual Global Healthcare Conference. The company leverages generative AI integrated with synthetic biology to accelerate drug discovery and is advancing its own pipeline, including ABS-201 for hair regrowth and endometriosis. …

Navigator Gas Releases 2025 Sustainability Report

Navigator Gas Releases 2025 Sustainability Report

Navigator Holdings Ltd., a NYSE-listed leader in handysize liquefied gas carriers, released its 2025 Sustainability Report showcasing significant progress in corporate governance, diversity, emission reductions, and investment in environmentally sustainable technologies including ammonia and dual-fuel ethylene vessels. The company reported a 2.97% …

NANO Nuclear’s KRONOS MMR™ and the University of Illinois Urbana-Champaign Advance to Next Regulatory Milestone as U.S. NRC Formally Accepts Construction Permit Application for Review

NANO Nuclear’s KRONOS MMR™ and the University of Illinois Urbana-Champaign Advance to Next Regulatory Milestone as U.S. NRC Formally Accepts Construction Permit Application for Review

NANO Nuclear Energy Inc. announced that the U.S. Nuclear Regulatory Commission has formally accepted the Construction Permit Application for their KRONOS MMR™ micro modular reactor at the University of Illinois Urbana-Champaign. This acceptance initiates the formal licensing review process, marking a major milestone as KRONOS MMR™ becomes the first…

Applied Materials Announces Broadcom as EPIC Innovation Partner

Applied Materials Announces Broadcom as EPIC Innovation Partner

Applied Materials announced that Broadcom will join its EPIC innovation platform to collaborate on R&D for advanced packaging technologies essential for next-generation AI chips. This partnership leverages Applied's global innovation centers, including the new EPIC Center in Silicon Valley, aiming to expedite the commercialization of high-performan…

Protara Therapeutics to Present at the TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA

Protara Therapeutics to Present at the TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA

Protara Therapeutics, a clinical-stage biotech company, announced participation in a virtual fireside chat at the TD Cowen 7th Annual Oncology Innovation Summit. The company will discuss its lead candidate TARA-002 in Phase 2 trials for non-muscle invasive bladder cancer and lymphatic malformations, as well as its development of IV Choline Chloride…

Smithfield Foods Awards 12 Impact Grants Nationwide

Smithfield Foods Awards 12 Impact Grants Nationwide

Smithfield Foods has awarded over $280,000 in Impact Grants to 12 nonprofit organizations addressing community needs such as hunger relief, education, and local infrastructure. This funding builds on their prior $24 million investment in 2025 and supports initiatives including food security, literacy, emergency services, and youth programs in areas…

Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants

Annovis Announces Pricing of $15.0 Million Public Offering of Common Stock and Accompanying Warrants

Annovis Bio, a clinical-stage biotech company focusing on therapies for Alzheimer's and Parkinson's diseases, announced the pricing of an underwritten public offering of common stock and warrants aiming to raise approximately $15 million. The proceeds will primarily support continued clinical development of buntanetap and general corporate purposes…

Freshworks Announces Winners of the 2026 Global Customer Awards

Freshworks Announces Winners of the 2026 Global Customer Awards

Freshworks Inc. announced the winners of its inaugural 2026 Global Customer Awards, recognizing customers from various industries who have successfully leveraged Freshworks' AI-enabled service platforms to drive significant operational efficiencies, improve customer satisfaction, and advance digital transformation. The awards highlight achievements…

Daniel Kelly Joins Talen as General Counsel and Corporate Secretary

Daniel Kelly Joins Talen as General Counsel and Corporate Secretary

Talen Energy Corporation announced the appointment of Daniel Kelly as General Counsel and Corporate Secretary. Kelly brings 25 years of legal and governance experience, previously holding a senior role at Vistra Corp. He replaces John Wander, who has retired after three years in the position. Kelly will oversee legal, regulatory, and corporate gove…

Madrigal to Present New Data from the Company’s MASH Program at EASL 2026 Demonstrating the Effects of Rezdiffra on Markers of Cardiovascular and Portal Hypertension Risk

Madrigal to Present New Data from the Company’s MASH Program at EASL 2026 Demonstrating the Effects of Rezdiffra on Markers of Cardiovascular and Portal Hypertension Risk

Madrigal Pharmaceuticals announced that new data from its MASH program will be presented at the EASL Congress 2026. The data includes secondary analyses from Phase 3 trials demonstrating Rezdiffra's positive impact on lipid profiles and portal hypertension risk markers in patients with metabolic dysfunction-associated steatohepatitis (MASH). The pr…

EuroDry Ltd. Reports Results for the Quarter Ended March 31, 2026 and Announces the order for two Modern 82,000 DWT Kamsarmax Bulk Carriers

EuroDry Ltd. Reports Results for the Quarter Ended March 31, 2026 and Announces the order for two Modern 82,000 DWT Kamsarmax Bulk Carriers

EuroDry Ltd., a US-listed drybulk shipping company, reported a positive turnaround in Q1 2026 with net income attributable to controlling shareholders of $0.26 million, a significant improvement from a loss in the same period last year. The company saw a 38.9% increase in net revenues driven by a doubling of the average time charter equivalent rate…

Dyne Therapeutics Announces Initiation of Phase 3 FORZETTO Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD) Ahead of Planned BLA Submission for U.S. Accelerated Approval

Dyne Therapeutics Announces Initiation of Phase 3 FORZETTO Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD) Ahead of Planned BLA Submission for U.S. Accelerated Approval

Dyne Therapeutics has commenced the Phase 3 FORZETTO clinical trial testing z-rostudirsen in patients with Duchenne muscular dystrophy amenable to exon 51 skipping. The 72-week, placebo-controlled trial aims to confirm the drug's efficacy and safety with a primary endpoint focused on muscle function. The trial protocol aligns with FDA guidelines to…